Top Markets
Coin of the day
Pear Therapeutics, Inc. Pear Therapeutics, Inc.

Pear Therapeutics, Inc.

PEAR
Rank in Stocks #40500
Pear Therapeutics, Inc. is a commercial-phase medical company focused on... Pear Therapeutics, Inc. is a commercial-phase medical company focused on inventing and distributing digital therapeutics. Its current offerings include reSET, which addresses substance use disorders involving alcohol, cannabis, cocaine, and stimulants; reSET-O, prescribed alongside buprenorphine for opioid use disorder; and Somryst, a digital solution for chronic insomnia. Beyond these marketed therapies, the company maintains a robust development pipeline of 14 prospective products. These investigational treatments span various therapeutic areas, encompassing psychiatry, neurology, and non-central nervous system conditions like gastrointestinal, oncological, and cardiovascular disorders. Founded in 2013, Pear Therapeutics, Inc. is headquartered in Boston, Massachusetts.
Share Price
$0.0048
Last synced: 2023-05-23
Market Cap
$132.48K
Change (1 day)
-20.00%
Change (1 year)
0.00%
Country
US
Trade Pear Therapeutics, Inc. (PEAR)

Category

Stock split history for Pear Therapeutics, Inc. (PEAR)
Pear Therapeutics, Inc. stock (symbol: PEAR) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 13, 2026.
One PEAR share bought prior to Aug 13, 2026 would equal to 0 PEAR shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors